Mandate

Vinge advises Electra Gruppen in connection with its listing on NASDAQ OMX

May 28, 2009

Vinge is advising Electra Gruppen AB in connection with its change of exchange listing from First North to NASDAQ OMX Stockholm. The first day of trading is estimated to be 1 June 2009.

Trading in respect of Electra Gruppen’s shares on First North will cease in connection with the listing on NASDAQ OMX. No new shares will be issued in connection with the listing.

Electra Gruppen owns chain stores selling home electronics and telecommunications products. The company was founded in 1949 and has its head office and conducts most of its operations in Kalmar. Electra Gruppen has approximately 90 employees.

Vinge’s team consists of responsible partner Jesper Ottergren together with associates Christian Lindhé, Marcus Bergdahl, Ida Christensson and Anna Bjering.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026